Tag Archives: proteomics

Job: Postdoc position on computational proteomics

A postdoc position is available in the Cellular Network Biology group at the Novo Nordisk Foundation Center for Protein Research (CPR). The group focuses on network-based analysis of proteins and their posttranslational modifications in the context of cellular signaling and disease. The postdoc will work on developing novel computational methods for analysis of proteomics data and apply them to unpublished state-of-the-art mass-spectrometry data in close collaboration with the proteomics groups at CPR.

Candidates for the postdoctoral positions must hold a PhD degree (or equivalent) within a relevant discipline and have experience with programming and large-scale data analysis. The successful candidates will have strong qualifications or experience within several of the following areas:

  • Bioinformatics / computational biology
  • Statistical data analysis
  • Mass spectrometry / proteomics
  • Programming in Python and/or R

For further details please see the official job advert.

Update: The BuzzCloud for 2014

It has been almost two years since the last BuzzCloud update. So this update is well overdue:

BuzzCloud 2014

As you can see two of the biggest buzzwords in the cloud are computational proteomics and precision medicine. I am obviously quite happy to see that, considering that I currently have an open postdoc position in proteome bioinformatics and is involved in work on data mining of electronic health records.

Job: Postdoc position in proteome bioinformatics

I currently have an opening for a two-year postdoc position in my group Cellular Network Biology at the Novo Nordisk Foundation Center for Protein Research.

The project primarily relates to on computational analysis of mass-spectrometry-based proteomics data. This includes developing new, improved methods for analyzing spectra, optimization of analysis protocols, and application of these to specific datasets. The focus will be on improving the identification of post-translationally modified peptides, which arise in cellular signaling processes and through chemical modification, in particular in ancient samples, which may also consist of mixtures of species. The work will involve close collaboration with the Proteomics Program.

The closing date for applications is December 31, 2014. For further details refer to the job advert.

Job: Ph.D. stipend in systems biology and bioinformatics

I currently have an open position for a Ph.D. student in my group Cellular Network Biology. My group is part part of the Novo Nordisk Foundation Center for Protein Research (CPR) and is financially supported by the Faculty of Health and Medical Sciences, University of Copenhagen.

The project will primarily focus on developing new, improved methodologies for analysis of large-scale datasets, e.g. from mass spectrometry, in the context of protein interaction networks, protein localization, and expression. In doing so, the aim is both to test scientific hypotheses and to improve existing resources developed within the group, such as STRING and COMPARTMENTS. Candidates are thus expected to have experience with programming and statistics.

The closing date for applications is June 30, 2014. For further details refer to the job advert.

Announcement: PTMs in Cell Signaling conference

Two years ago, I was one of the organizers of the 2nd Copenhagen Bioscience Conference entitled PTMs in Cell Signaling. I think it is fair to describe it as a highly successful meeting, and it is my great pleasure to announce that we will be organizing a second meeting on the topic September 14-18, 2014.

CBC6 poster

My co-chairs Jeremy Austin Daniel, Michael Lund Nielsen, and Amilcar Flores Morales have managed to put together the following excellent lineup of invited speakers:

Alfonso Valencia, Chris Sander, David Komander, Gary Nolan, Genevieve Almouzni, Guillermo Montoya, Hanno Steen, Henrik Daub, John Blenis, John Diffley, John Tainer, Karolin Luger, Marcus Bantscheff, Margaret Goodell, Matthias Mann, Michael Yaffe, Natalie Ahn, Pedro Beltrao, Stephen Elledge, Tanya Paull, Tony Hunter, Yang Shi, Yehudit Bergman, and Yosef Shiloh.

All conference expenses are covered, which means that there will be no registration fee and no expenses for accommodation or food. You will have to cover your own travel expenses, though.

Participants will be selected based on abstract submission, which is open until June 9, 2014. For more information please see the conference website.

Announcement: PTMs In Cell Signaling

It is my great pleasure to announce the 2nd Copenhagen Bioscience conference “PTMs In Cell Signaling”, which will take place in Helsingør, Denmark on December 3-5, 2012.

The conference will feature a truly excellent lineup of speakers: Philippe Bastiaens, Søren Brunak, Ivan Dikic, Gerald Hart, Tim Hunt, Steve Jackson, Doug Lauffenburger, Jiri Lukas, Matthias Mann, Andre Nussenzweig, Brenda Schulman, Henrik Semb, Eric Verdin, Forest White, Michael Yaffe, and Juleen Zierath.

The conferences is limited to 220 participants. It is fully sponsored by the Novo Nordisk Foundation who covers the conference fee, hotel, transport and meals during the conference. Participants cover their own travel expenses.

To find out more, please check the conference web site.

Analysis: Limited agreement among lists of Cdc28p substrates

A collaboration between the Morgan lab at UCSF and the Gygi lab at Harvard has resulted in a paper by Holt et al. in Science, which reports the identification of several hundred substrates of the central cell-cycle kinase Cdc28p (also known as Cdk1) in the budding yeast Saccharomyces cerevisiae:

Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution.

To explore the mechanisms and evolution of cell-cycle control, we analyzed the position and conservation of large numbers of phosphorylation sites for the cyclin-dependent kinase Cdk1 in the budding yeast Saccharomyces cerevisiae. We combined specific chemical inhibition of Cdk1 with quantitative mass spectrometry to identify the positions of 547 phosphorylation sites on 308 Cdk1 substrates in vivo. Comparisons of these substrates with orthologs throughout the ascomycete lineage revealed that the position of most phosphorylation sites is not conserved in evolution; instead, clusters of sites shift position in rapidly evolving disordered regions. We propose that the regulation of protein function by phosphorylation often depends on simple nonspecific mechanisms that disrupt or enhance protein-protein interactions. The gain or loss of phosphorylation sites in rapidly evolving regions could facilitate the evolution of kinase-signaling circuits.

The paper makes several interested in analyses and observations. However, I found the comparison to the previous study of Cdc28p substrates by Ubersax et al. from the Morgan lab to be less detailed than I had hoped for:

Phosphorylation of Cdk1 consensus sites was observed on 67% (122 of 181) of proteins previously identified as Cdk1 substrates in vitro (4). Sixty-six percent (80 of 122) of these proteins contained sites at which phosphorylation decreased (log2 H/L < –1) after inhibition of Cdk1 (only 45 of 122 are expected if there is no correlation between the experiments in vitro and in vivo; χ2 test, P < 10-10).

In other words, 44% (80 of 181) of Cdc28p substrates identified in the old study were confirmed by the new study, and only 26% (80 of 308) of the Cdc28p substrates identified in the new study are supported by the old study. There are many possible explanations for this discrepancy

Depth of the mass spectrometry

It is notoriously difficult to identify peptides from low-abundance proteins in mass spectrometry. In the new mass spectrometry study, the authors were able to map 8710 precise phosphorylation sites on 1957 proteins. However, budding yeast is estimated to express in the order of 4500 distinct proteins during exponential growth (Gavin et al., 2006). Assuming that the majority of these proteins contain sites that are phosphorylated during at least part of the mitotic cell cycle, it is likely that a considerable number of low-abundance Cdc28p substrates identified in the old study have been missed in the new study.

Biases in phosphopeptide enrichment

When doing phosphoproteomics, it is necessary to first enrich for phosphopeptides to improve the coverage. To this end, Holt et al. used immobilized metal affinity chromatography (IMAC). In 2007, the Aebersold group at ETH published a paper showing that different purification methods lead to isolation of different, partially overlapping segments of the phosphoproteome. Specifically, they showed that IMAC enrichment biases the data towards isolation of multiply phosphorylated peptides. Given that only a single purification method was used, it is likely that in vivo Cdc28p substrates may have been missed in the new study, in particular if the peptides contain only a single phosphorylation site.

In vitro vs. in vivo conditions

The old study by Ubersax et al. was done performed on cell lysate, which is an in vitro strategy (although all other proteins expressed during the cell cycle are present). It is thus likely that some of the proteins that are phosphorylated by Cdc28p under these conditions are nonetheless not in vivo Cdc28p substrates.

Can we do better?

As always, it is easy to point out potential flaws in other people’s data sets; however, it is much more constructive to do something about the problems. The challenge is thus to construct a larger and more reliable set of Cdc28p substrates by combining the data from the two studies.

To check the feasibility of assigning confidence scores to different putative Cdc28p substrates, I tested if the fold change observed in the new study correlates with the chance that the substrate was also identified in the old study. To this end, I divided the 308 Cdc28p substrates from the new studies into two groups and constructed histograms of the fold changes for each group:

Phosphorylation ratios from Holt et al.

The fold changes are clearly skewed towards larger negative values for the Cdc28p substrates also identified by the old study relative to the proteins that were not previously identified as Cdc28p substrates. This difference is statistically significant at P < 1% according to the Kolmogorov-Smirnov test. This suggests that the observed fold changes in the new mass spectrometry study correlates with the likelihood that the proteins are true Cdc28p substrates.

The old study gave rise to so-called P-score for the individual proteins (not to be confused with P-values). I decided to test if these too can be used as quality scores, I constructed an equivalent histogram in which the Cdc28p substrates found in the old study were divided into two groups based on whether or not they were also found in the new study:

P-scores from Ubersax et al.

In this case, no obvious trend is seen and a Kolmogorov-Smirnov test indeed reveals no statistically significant difference between the two distributions. Surprisingly, the P-scores do thus not appear to be useful quality scores for the putative Cdc28p substrates.

Given the two sets of putative Cdc28 substrates, only one of which can be ranked by reliability, how can we create a better combined set? If one aims for the high accuracy at the price of low coverage, one could obviously choose to trust only the substrates identified by both screens. However, given the caveats regarding depth of mass spectrometry and biases arising from the enrichment procedure, I would be hesitant to use this approach. Alternatively, one could aim for maximal coverage at the price of accuracy by trusting all sites identified by either study. However, seeing the large fraction of novel substrates identified by Holt et al. with a log2-ratio only slightly below -1, I would personally tend to apply a more stringent threshold to the data from the new study by Holt et al., for example requiring log2-ratio below -2, before merging the sets of substrates from the two studies.

WebCiteCite this post